Fpc Investment Advisory, Inc. Astrazeneca PLC Transaction History
Fpc Investment Advisory, Inc.
- $146 Billion
- Q1 2025
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,418Shares Held
507MCall Options Held
8.14MPut Options Held
3.15M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.88 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.76 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.42 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.16 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.13 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...